Evidence map›Paper›PMID 10377172›Full record

ArticleThe Journal of clinical investigation1999

Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection.

A Le Moine, V Flamand, F X Demoor, J C Noël, M Surquin, R Kiss, M A Nahori, M Pretolani, M Goldman, D Abramowicz

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 116 citations in OpenAlex.

  1. How Cytokines Regulate Immune Response Toward Chronic Allograft Rejection?Results and problems in cell differentiation · 2026
    Review
  2. The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  3. Review
  4. Article
  5. Relaxin in fibrotic ligament diseases: Its regulatory role and mechanism.Frontiers in cell and developmental biology · 2023
    Review
  6. Immune Cells in Subretinal Wound Healing and Fibrosis.Frontiers in cellular neuroscience · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. A Player and Coordinator: The Versatile Roles of Eosinophils in the Immune System.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2016
    Review
  13. Review
  14. Leukocytes: The Double-Edged Sword in Fibrosis.Mediators of inflammation · 2015
    Review
  15. Cytokine mediated tissue fibrosis.Biochimica et biophysica acta · 2013
    Review
  16. Article
  17. Article
  18. Article
  19. Antifibrosis: to reverse the irreversible.Clinical reviews in allergy & immunology · 2010
    Review
  20. Mechanism of cellular rejection in transplantation.Pediatric nephrology (Berlin, Germany) · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

A Le MoineLaboratory of Experimental Immunology, Faculty of Médecine, Department of Nephrology, Hôpital Erasme, Paris, France. alemoine@ulb.ac.be
V Flamand
F X Demoor
J C Noël
M Surquin
R Kiss
M A Nahori
M Pretolani
M Goldman
D Abramowicz
Czech Academy of Sciences, Institute of Experimental Medicine · CZErasmus Hospital · BEInserm · FRUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

C57BL/6 mice injected with the 145-2C11 anti-CD3 mAb and grafted with MHC class II disparate bm12 skin develop a chronic rejection characterized by interstitial dermal fibrosis, a marked eosinophil infiltrate, and an obliterative intimal vasculopathy. Because these changes occur in the absence of alloreactive antibodies, we examined the contribution of cytokines in their pathogenesis. Chronically rejected grafts showed a marked accumulation of both IL-4 and IL-5 mRNA. Mixed lymphocyte reaction experiments established that mice undergoing chronic rejection were primed for IL-4, IL-5, and IL-10 secretion. In vivo administration of anti-IL-4 mAb completely prevented allograft vasculopathy as well as graft eosinophil infiltration and dermal fibrosis. Injection of anti-IL-5 mAb or the use of IL-5-deficient mice as recipients also resulted in the lack of eosinophil infiltration or dermal fibrosis, but these mice did develop allograft vasculopathy. Administration of anti-IL-10 mAb did not influence any histologic parameter of chronic rejection. Thus, in this model, IL-4- and IL-5-mediated tissue allograft eosinophil infiltration is associated with interstitial fibrosis. IL-4, but not eosinophils, is also required for the development of obliterative graft arteriolopathy.

Indexed as

AnimalsAntibodies, MonoclonalChronic DiseaseCytokinesEosinophilsFemaleGene Expression RegulationGraft RejectionInterleukin-10Interleukin-4Interleukin-5Lymphocyte Culture Test, MixedMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutAntibodies, MonoclonalCytokinesInterleukin-10Interleukin-4Interleukin-5

Identifiers

PMID10377172
PMCPMC408380
OpenAlexW2034699026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.